142 related articles for article (PubMed ID: 37690821)
1. Hypericin as a promising natural bioactive naphthodianthrone: A review of its pharmacology, pharmacokinetics, toxicity, and safety.
Peng Z; Lu J; Liu K; Xie L; Wang Y; Cai C; Yang D; Xi J; Yan C; Li X; Shi M
Phytother Res; 2023 Dec; 37(12):5639-5656. PubMed ID: 37690821
[TBL] [Abstract][Full Text] [Related]
2. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.
Kleemann B; Loos B; Scriba TJ; Lang D; Davids LM
PLoS One; 2014; 9(7):e103762. PubMed ID: 25076130
[TBL] [Abstract][Full Text] [Related]
3. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).
Peebles KA; Baker RK; Kurz EU; Schneider BJ; Kroll DJ
Biochem Pharmacol; 2001 Oct; 62(8):1059-70. PubMed ID: 11597574
[TBL] [Abstract][Full Text] [Related]
4. Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells.
Jendželovská Z; Jendželovský R; Hiľovská L; Kovaľ J; Mikeš J; Fedoročko P
Toxicol In Vitro; 2014 Oct; 28(7):1259-73. PubMed ID: 24994473
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Photosensitizing Dyes Fagopyrin and Hypericin on Planktonic Growth and Multicellular Life in Budding Yeast.
Sytar O; Kotta K; Valasiadis D; Kosyan A; Brestic M; Koidou V; Papadopoulou E; Kroustalaki M; Emmanouilidou C; Pashalidis A; Avdikos I; Hilioti Z
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443298
[TBL] [Abstract][Full Text] [Related]
7. Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules.
Miskovsky P
Curr Drug Targets; 2002 Feb; 3(1):55-84. PubMed ID: 11899265
[TBL] [Abstract][Full Text] [Related]
8. Hypericin-mediated photooxidative damage of α-crystallin in human lens epithelial cells.
Ehrenshaft M; Roberts JE; Mason RP
Free Radic Biol Med; 2013 Jul; 60():347-54. PubMed ID: 23453985
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations.
Draves AH; Walker SE
Can J Clin Pharmacol; 2003; 10(3):114-8. PubMed ID: 14506510
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus.
Butterweck V; Böckers T; Korte B; Wittkowski W; Winterhoff H
Brain Res; 2002 Mar; 930(1-2):21-9. PubMed ID: 11879791
[TBL] [Abstract][Full Text] [Related]
11. Effect of topical application of Hypericum perforatum extract (St. John's wort) on skin sensitivity to solar simulated radiation.
Schempp CM; Lüdtke R; Winghofer B; Simon JC
Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):125-8. PubMed ID: 10885442
[TBL] [Abstract][Full Text] [Related]
12. Hypericin in photobiological assays: An overview.
de Andrade GP; de Souza TFM; Cerchiaro G; Pinhal MADS; Ribeiro AO; Girão MJBC
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102343. PubMed ID: 34038765
[TBL] [Abstract][Full Text] [Related]
13. Hypericin, a medicinal compound from St. John's Wort, inhibits genotoxicity induced by mutagenic agents in V79 cells.
de Souza LM; de Sousa FD; Cruz RCR; Tavares DC; Francielli de Oliveira P
Drug Chem Toxicol; 2022 May; 45(3):1302-1307. PubMed ID: 33050761
[TBL] [Abstract][Full Text] [Related]
14. Hypericin-mediated photodynamic therapy for the treatment of cancer: a review.
Dong X; Zeng Y; Zhang Z; Fu J; You L; He Y; Hao Y; Gu Z; Yu Z; Qu C; Yin X; Ni J; Cruz LJ
J Pharm Pharmacol; 2021 Mar; 73(4):425-436. PubMed ID: 33793828
[TBL] [Abstract][Full Text] [Related]
15. Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor binding.
Raffa RB
Life Sci; 1998; 62(16):PL265-70. PubMed ID: 9585174
[TBL] [Abstract][Full Text] [Related]
16. Molecular and biochemical characterization of an enzyme responsible for the formation of hypericin in St. John's wort (Hypericum perforatum L.).
Bais HP; Vepachedu R; Lawrence CB; Stermitz FR; Vivanco JM
J Biol Chem; 2003 Aug; 278(34):32413-22. PubMed ID: 12799379
[TBL] [Abstract][Full Text] [Related]
17. The multifaceted photocytotoxic profile of hypericin.
Theodossiou TA; Hothersall JS; De Witte PA; Pantos A; Agostinis P
Mol Pharm; 2009; 6(6):1775-89. PubMed ID: 19739671
[TBL] [Abstract][Full Text] [Related]
18. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
[TBL] [Abstract][Full Text] [Related]
19. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral administration ofHypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation.
Schempp CM; Winghofer B; Müller K; Schulte-Mönting J; Mannel M; Schöpf E; Simon JC
Phytother Res; 2003 Feb; 17(2):141-6. PubMed ID: 12601676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
